SITAGLO-MET (sitagliptin hydrochloride monohydrate and metformin hydrochloride) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin is appropriate.
Tablet Description
Light pink colored, capsule shaped, film-coated tablet debossed with ‘SM1’ on one side and plain on the other side.
SITAGLO-MET (sitagliptin hydrochloride monohydrate and metformin hydrochloride) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin is appropriate.
Tablet Description
Pink coloured, capsule shaped, film-coated tablet debossed with 'SM2' on one side and plain on the other side.
SITAGLO-MET (sitagliptin hydrochloride monohydrate and metformin hydrochloride) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin is appropriate.
Tablet Description
Red coloured, capsule shaped, film-coated tablet debossed with 'SM3' on one side and plain on the other side.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Generic Name: Sitagliptin + Metformin
PBS Listed: ✔
RPBS: ✘
Strength: 50/1000
Dosage: Tablet, film coated
Pack Size: 56
Schedule: S4
Shelf Life: 24 Months
Innovator: Janumet
Warnings
See Product Information and Consumer Medicine Information for this product
SITAGLO-MET (sitagliptin hydrochloride monohydrate and metformin hydrochloride) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin is appropriate.
Tablet Description
Light pink colored, capsule shaped, film-coated tablet debossed with ‘SM1’ on one side and plain on the other side.
SITAGLO-MET (sitagliptin hydrochloride monohydrate and metformin hydrochloride) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin is appropriate.
Tablet Description
Pink coloured, capsule shaped, film-coated tablet debossed with 'SM2' on one side and plain on the other side.
SITAGLO-MET (sitagliptin hydrochloride monohydrate and metformin hydrochloride) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin is appropriate.
Tablet Description
Red coloured, capsule shaped, film-coated tablet debossed with 'SM3' on one side and plain on the other side.
SITAGLO-MET (sitagliptin hydrochloride monohydrate and metformin hydrochloride) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin is appropriate.
Tablet Description
Light pink colored, capsule shaped, film-coated tablet debossed with ‘SM1’ on one side and plain on the other side.
SITAGLO-MET (sitagliptin hydrochloride monohydrate and metformin hydrochloride) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin is appropriate.
Tablet Description
Pink coloured, capsule shaped, film-coated tablet debossed with 'SM2' on one side and plain on the other side.
SITAGLO-MET (sitagliptin hydrochloride monohydrate and metformin hydrochloride) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin is appropriate.
Tablet Description
Red coloured, capsule shaped, film-coated tablet debossed with 'SM3' on one side and plain on the other side.
SITAGLO-MET (sitagliptin hydrochloride monohydrate and metformin hydrochloride) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin is appropriate.
Tablet Description
Light pink colored, capsule shaped, film-coated tablet debossed with ‘SM1’ on one side and plain on the other side.
SITAGLO-MET (sitagliptin hydrochloride monohydrate and metformin hydrochloride) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin is appropriate.
Tablet Description
Pink coloured, capsule shaped, film-coated tablet debossed with 'SM2' on one side and plain on the other side.
SITAGLO-MET (sitagliptin hydrochloride monohydrate and metformin hydrochloride) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin is appropriate.
Tablet Description
Red coloured, capsule shaped, film-coated tablet debossed with 'SM3' on one side and plain on the other side.